Vynleads (VYND) Shares Outstanding (Diluted Average) (2021 - 2025)
Vynleads (VYND) reported Shares Outstanding (Diluted Average) of $18.3 million for Q4 2025, up 43.35% year-over-year from $12.8 million in Q4 2024, and little changed quarter-over-quarter from $18.3 million in Q3 2025.
Vynleads (VYND) Shares Outstanding (Diluted Average) (2021 - 2025) Analysis & Trends
Vynleads (VYND) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $18.3 million in Q4 2025.
- Shares Outstanding (Diluted Average) for Q4 2025 came in at $18.3 million, up 43.35% year-over-year; the trailing twelve-month figure through Dec 2025 was $18.3 million (up 43.35% YoY), and the FY2025 annual result was $18.3 million, up 43.35% from the prior year.
- Shares Outstanding (Diluted Average) steadied at $18.3 million in Q4 2025 per VYND's latest filing, from $18.3 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $18.3 million in Q1 2025 and troughed at $11.6 million in Q2 2021.
- A 5-year average of $13.1 million and a median of $11.6 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) changed 0.0% in 2023, then jumped 58.0% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $11.6 million in 2021, then grew by 0.03% to $11.6 million in 2022, then changed by 0.0% to $11.6 million in 2023, then increased by 10.22% to $12.8 million in 2024, then soared by 43.35% to $18.3 million in 2025.
- Business Quant data shows VYND's Shares Outstanding (Diluted Average) at $18.3 million in Q4 2025, $18.3 million in Q3 2025, and $18.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 165.99 Mn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 221.32 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 85.01 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | 82.39 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 199.05 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | 128.29 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | 195.16 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | 130.88 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 45.94 Mn |
| 10 | Vynleads | - | - | -2,028.00 | 18.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.33 Mn |
| Sep 30, 2025 | 18.33 Mn |
| Jun 30, 2025 | 18.33 Mn |
| Mar 31, 2025 | 18.33 Mn |
| Dec 31, 2024 | 12.79 Mn |
| Sep 30, 2024 | 11.70 Mn |
| Jun 30, 2024 | 11.60 Mn |
| Mar 31, 2024 | 11.60 Mn |
| Dec 31, 2023 | 11.60 Mn |
| Sep 30, 2023 | 11.60 Mn |
| Jun 30, 2023 | 11.60 Mn |
| Mar 31, 2023 | 11.60 Mn |
| Dec 31, 2022 | 11.60 Mn |
| Sep 30, 2022 | 11.60 Mn |
| Jun 30, 2022 | 11.60 Mn |
| Mar 31, 2022 | 11.60 Mn |
| Dec 31, 2021 | 11.60 Mn |
| Sep 30, 2021 | 11.60 Mn |
| Jun 30, 2021 | 11.59 Mn |